Endra And TAEUS Technology In NAFLD Diagnosis [Seeking Alpha]
ENDRA Life Sciences Inc. (NDRA)
US:NASDAQ Investor Relations:
investors.endrainc.com/prviewer/release_only/id/2807436
Company Research
Source: Seeking Alpha
Endra And TAEUS Technology In NAFLD Diagnosis Summary Non-invasive diagnostic imaging technologies are increasingly becoming important in NAFLD and NASH clinical research and drug development. The addressable market for non-invasive diagnostic imaging technologies is expected to grow in upcoming years as more knowledge is acquired from its clinical effectiveness. The TAEUS technology by ENDRA is innovative, cost effective but more importantly, adaptable to existing ultrasounds. With NAFLD and NASH becoming a global crisis, there would be increased clinical demand and need for adaptable, low-cost, effective, non-invasive diagnostic imaging technology like TAEUS. Endra recently announced preliminary clinical data demonstrating the effectiveness and sensitivity of TAEUS technology in the measurement of liver fat. ENDRA ( At present, NASH is diagnosed by liver biopsy and that remains the gold standard for the foreseeable future. In addition, the clinical endpoints in Phase 3 NASH trials
Show less
Read more
Impact Snapshot
Event Time:
NDRA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NDRA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NDRA alerts
High impacting ENDRA Life Sciences Inc. news events
Weekly update
A roundup of the hottest topics
NDRA
News
- ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
- ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateBusiness Wire
- ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024 [Yahoo! Finance]Yahoo! Finance
- ENDRA Life Sciences to Report Fourth Quarter 2023 Financial Results on March 28, 2024Business Wire
NDRA
Sec Filings
- 4/19/24 - Form S-1
- 4/4/24 - Form EFFECT
- 4/3/24 - Form 424B5
- NDRA's page on the SEC website